Congenital Factor V Deficient Plasma

• Human plasma from donor with congenital FV Deficiency
• Substrate quality
• <1% FV Activity by one stage clotting assay
• No buffers or preservatives added

When doing factor assays, it is critical to have only a single factor deficient in the substrate plasma.

*George King Bio-Medical, Inc opened December 20, 1973. Due to this, the majority of our products fall in Preamendment Status